Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study

Background: Diffusion-weighted imaging (DWI) with the intravoxel incoherent motion (IVIM) model has shown promising results for providing both diffusion and perfusion information in cervical cancer; however, its use to predict and monitor the efficacy of neoadjuvant chemotherapy (NACT) in cervical cancer is relatively rare. The study aimed to evaluate the use of DWI with IVIM and monoexponential models to predict and monitor the efficacy of NACT in cervical cancer. Methods: Forty-two patients with primary cervical cancer underwent magnetic resonance exams at 3 time points (pre-NACT, 3 weeks after the first NACT cycle, and 3 weeks after the second NACT cycle). The response to treatment was determined according to the response evaluation criteria in solid tumors 3 weeks after the second NACT treatment, and the subjects were classified as two groups: responders and nonresponders groups. The apparent diffusion coefficient (ADC), true diffusion coefficient (D), perfusion-related pseudo-diffusion coefficient (D*), and perfusion fraction (f) values were determined. The differences in IVIM-derived variables and ADC between the different groups at the different time points were calculated using an independent samples t-test. Results: The D and ADC values were all significantly higher for the responders than for the nonresponders at all 3 time points, but no significant differences were observed in the D* and f values. An analysis of the receiver operating characteristic (ROC) curves indicated that a D value threshold <0.93 × 10−3 mm2/s and an ADC threshold <1.11 × 10−3 mm2/s could differentiate responders from nonresponders at pre-NACT time point, yielding area under the curve (AUC) of which were 0.771 and 0.806, respectively. The ROC indicated that the AUCs of D and ADC at the 3 weeks after the first NACT cycle and 3 weeks after the second NACT cycle were 0.823, 0.763, and 0.787, 0.794, respectively. The AUC values of D and ADC at these 3 time points were not significantly different (P = 0.641, 0.512, and 0.547, respectively). Conclusions: D and ADC values may be useful for predicting and monitoring the efficacy of NACT in cervical cancer. An IVIM model may be equal to monoexponential model in predicting and monitoring the efficacy of NACT in cervical cancer.

[1]  P. Summers,et al.  Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy , 2011, La radiologia medica.

[2]  Jian Z. Wang,et al.  Ultra‐early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer , 2010, Cancer.

[3]  T. Sugiyama,et al.  Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancer. , 2010, Oncology letters.

[4]  Martin O. Leach,et al.  Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial , 2009, European Radiology.

[5]  N. Hong,et al.  Quantitative Measurement of Cerebral Perfusion with Intravoxel Incoherent Motion in Acute Ischemia Stroke: Initial Clinical Experience , 2015, Chinese medical journal.

[6]  J. Ledermann,et al.  A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer , 2013, British Journal of Cancer.

[7]  F. Gilbert,et al.  Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. , 2008, Gynecologic oncology.

[8]  N. Umesaki,et al.  Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer , 1999, British Journal of Cancer.

[9]  Leening P. Liu,et al.  Monitoring the Progression of Renal Fibrosis by T2-weighted Signal Intensity and Diffusion Weighted Magnetic Resonance Imaging in Cisplatin induced Rat Models , 2015, Chinese medical journal.

[10]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[11]  Hersh Chandarana,et al.  Comparison of Biexponential and Monoexponential Model of Diffusion Weighted Imaging in Evaluation of Renal Lesions: Preliminary Experience , 2010, Investigative radiology.

[12]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[13]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[14]  D. Collins,et al.  Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. , 2011, AJR. American journal of roentgenology.

[15]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[16]  S. Anteby,et al.  Neoadjuvant chemotherapy for locally advanced cervical cancer--where does it stand?: a review. , 1996, Obstetrical & gynecological survey.

[17]  Chun Fu,et al.  The Value of Diffusion-Weighted Magnetic Resonance Imaging in Assessing the Response of Locally Advanced Cervical Cancer to Neoadjuvant Chemotherapy , 2012, International Journal of Gynecologic Cancer.

[18]  Q. Chan,et al.  Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study , 2014, European Radiology.

[19]  John M Buatti,et al.  Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. , 2002, International journal of radiation oncology, biology, physics.

[20]  D. Collins,et al.  Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases , 2013, European Radiology.

[21]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[22]  Assessment of the Early Predictive Power of Quantitative Magnetic Resonance Imaging Parameters During Neoadjuvant Chemotherapy for Uterine Cervical Cancer , 2014, International Journal of Gynecologic Cancer.

[23]  D. Doval,et al.  A Retrospective Study of Patients With Locally Advanced Cancer of the Cervix Treated With Neoadjuvant Chemotherapy Followed by Radical Surgery , 2009, International Journal of Gynecologic Cancer.

[24]  Ji-Hong Liu,et al.  Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. , 2011, Gynecologic oncology.

[25]  Kathleen M Schmainda,et al.  The effect of low b‐values on the intravoxel incoherent motion derived pseudodiffusion parameter in liver , 2015, Magnetic resonance in medicine.